Repligen Corp financial data

Symbol
RGEN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 Seyon Street, Building 1, Suite 100, Waltham, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 393 % +63.8%
Quick Ratio 79.4 % +35.3%
Debt-to-equity 35.9 % +8.46%
Return On Equity 0.75 % -91.6%
Return On Assets 0.55 % -91.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.9 M shares +0.35%
Common Stock, Shares, Outstanding 55.8 M shares +0.35%
Entity Public Float 6.93 B USD -22.2%
Common Stock, Value, Issued 559 K USD +0.54%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 41.8 M USD -4.85%
Costs and Expenses 582 M USD +0.04%
Operating Income (Loss) 25.4 M USD -87.1%
Nonoperating Income (Expense) 4.8 M USD +1181%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 30.2 M USD -84.6%
Income Tax Expense (Benefit) 15.3 M USD -46.2%
Net Income (Loss) Attributable to Parent 14.8 M USD -91.2%
Earnings Per Share, Basic 0.27 USD/shares -91.1%
Earnings Per Share, Diluted 0.27 USD/shares -90.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 781 M USD +51.1%
Accounts Receivable, after Allowance for Credit Loss, Current 116 M USD -13.3%
Inventory, Net 198 M USD -19.1%
Other Assets, Current 13.3 M USD +29.6%
Assets, Current 1.13 B USD +11.2%
Deferred Income Tax Assets, Net 866 K USD +2.49%
Property, Plant and Equipment, Net 206 M USD +6.76%
Operating Lease, Right-of-Use Asset 135 M USD +10.5%
Intangible Assets, Net (Excluding Goodwill) 388 M USD +12%
Goodwill 986 M USD +15.1%
Other Assets, Noncurrent 956 K USD -19.5%
Assets 2.85 B USD +12.3%
Accounts Payable, Current 18.7 M USD -29.1%
Employee-related Liabilities, Current 20.5 M USD -0.29%
Accrued Liabilities, Current 56 M USD -3.59%
Liabilities, Current 178 M USD -56%
Operating Lease, Liability, Noncurrent 145 M USD +13.2%
Other Liabilities, Noncurrent 3.65 M USD -3.95%
Liabilities 879 M USD +47%
Accumulated Other Comprehensive Income (Loss), Net of Tax -42.7 M USD -37.2%
Retained Earnings (Accumulated Deficit) 441 M USD +3.48%
Stockholders' Equity Attributable to Parent 1.97 B USD +1.55%
Liabilities and Equity 2.85 B USD +12.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 44.7 M USD +301%
Net Cash Provided by (Used in) Financing Activities -8.97 M USD +6.16%
Net Cash Provided by (Used in) Investing Activities -8.36 M USD +11.4%
Common Stock, Shares Authorized 80 M shares 0%
Common Stock, Shares, Issued 55.8 M shares +0.35%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.3 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 781 M USD +51.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 988 K USD -4.36%
Deferred Tax Assets, Valuation Allowance 20 K USD +5.26%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 81.1 M USD +17.8%
Operating Lease, Liability 159 M USD +15%
Depreciation 37 M USD +54.8%
Payments to Acquire Property, Plant, and Equipment 8.35 M USD -1.92%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.25 M USD -97.9%
Lessee, Operating Lease, Liability, to be Paid 201 M USD +10%
Property, Plant and Equipment, Gross 341 M USD +16.5%
Operating Lease, Liability, Current 9.78 M USD +22.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25.6 M USD +18.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.6 M USD +13.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -833 K USD +25.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32.6 M USD +9.17%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25.4 M USD +17.8%
Deferred Tax Assets, Operating Loss Carryforwards 7.58 M USD -22.7%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 20.2 M USD -41.8%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 3.14 M USD +4.77%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.9 M USD +12.1%
Operating Lease, Payments 17.9 M USD +29.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 32.3 M USD +15.8%
Deferred Tax Assets, Net of Valuation Allowance 81.1 M USD +17.8%
Interest Expense 6.57 M USD +476%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%